September 4, 2018

CAR-TCR Summit

September 4-7 in Boston, Massachusetts

ICS is attending the 4th annual CAR-TCR Summit, the only dedicated, end-to-end summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies. The two main goals for this summit is to learn more about the discovery, translation and clinical development of CARTCR therapies, and ensure the accessibility, affordability and logistical delivery of current CAR-T cell therapies. Please reach out if you are attending and would like to set up time to talk.

ICS Team Members Attending CAR-TCR

Ann Pham, Senior Manager, Business Development
Ann Pham
Senior Manager, Business Development
Matthew Letow, Senior Director, Business Development
Matthew Letow
Senior Director, Business Development

2021 Clinical Trial Supply Roundtable Forum

3/30/2021 3:05:00 PM

2020 World Orphan Drug Congress

8/24/2020 8:00:00 AM

BIO International Convention 2020

6/8/2020 12:00:00 AM